Learn More
Clenbuterol (Clen), a beta(2)-agonist, is known to produce skeletal and myocardial hypertrophy. This compound has recently been used in combination with left ventricular assist devices for the treatment of end-stage heart failure to reverse or prevent the adverse effects of unloading-induced myocardial atrophy. However, the mechanisms of action of Clen on(More)
OBJECTIVE A prospective prevalence study of primary headache disorders in school going children (8-18 years) in Srinagar district of Kashmir valley was conducted. MATERIALS AND METHODS The study population comprised of a randomized sample of 5000 school going children in the age group of 8-18 years from various educational institutions of Srinagar city. A(More)
In cardiac hypertrophy and failure it has been shown that the amount of Na/Ca exchanger protein can increase. Several studies have investigated this modification in overt heart failure. However, the role of Na/Ca exchanger overexpression during the development of hypertrophy is unknown. To address this question we investigated Ca2+ regulation in an early(More)
  • 1